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Abstract 
Background: Gastric carcinoma (GC) is uncommon in dogs, except in predisposed breeds such as Belgian Shepherd 
dogs (BSD) of the Tervuren and Groenendael varieties. When GC is diagnosed in dogs it is often late in the disease, 
resulting in a poorer prognosis. The aim of this prospective clinical study was to investigate possible associations 
of gastric mucosal pathologies with clinical signs, laboratory test results and GC in BSD. An online survey gathered 
epidemiological data to generate potential risk factors for vomiting as the predominant gastric clinical sign, and 
supported patient recruitment for endoscopy. Canine Chronic Enteropathy Clinical Activity Index (CCECAI) score and 
signs of gastroesophageal reflux (GER) were used to allocate BSD older than five years to either Group A, with signs of 
gastric disease, or Group B, without signs. Findings in the clinical history, laboratory tests and gastric histopathology of 
endoscopic biopsies were statistically analysed in search of associations.
Results: The online survey included 232 responses. Logistic regression analysis recognized an association of vomiting 
with gagging, poor appetite and change in attitude. Recruitment for endoscopy included 16 BSD in Group A (mean 
age 9.1 ± 1.8 years, mean CCECAI = 3.1 ± 2.2 and signs of GER); and 11 in Group B (mean age 9.8 ± 1.4 years, CCE‑
CAI = 0, no signs of GER). Seven (25.9%) of the 27 BSD (Group A 4/16, Group B 3/11) had leukopenia. Serum C‑reactive 
protein tended to be increased with more advanced GC (P = 0.063). Frequency of GC, mucosal atrophy, mucous 
metaplasia, or glandular dysplasia did not differ between groups. GC was frequently diagnosed (6/27), even without 
clinical signs (2/11). The odds ratio for vomiting (OR = 9.9; P = 0.016) was increased only when glandular dysplasia 
was present. GC was associated with mucous metaplasia (P = 0.024) and glandular dysplasia (P = 0.006), but not with 
mucosal atrophy (P = 1).
Conclusions: GC can develop as an occult disease, associated with metaplasia and dysplasia of the gastric mucosa. 
Suggestive clinical signs, notably vomiting, should warrant timely endoscopy in BSD. Extensive endoscopic screening 
of asymptomatic dogs remains, however, unrealistic. Therefore, biomarkers of mucosal pathology preceding clinical 
illness are needed to support an indication for endoscopy and enable early diagnosis of GC.
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Background
Gastric carcinoma (GC), the most common gastric neo-
plasm in dogs, is relatively rare, representing less than 1% 
of canine cancers. However, a few lineages within cer-
tain dog breeds are predisposed to GC. GC is frequently 
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dogs (BSD) and some other dog breeds, including Bou-
vier des Flandres, Collie, Standard Poodle, Norwegian 
Elkhound and Chow-Chow [1–5]. A previous study in 
Finland found an increased risk ratio (RR = 19) for Ter-
vuren BSD undergoing endoscopy to be diagnosed with 
GC [6]. In the majority of cases, GC carries a very poor 
prognosis, since diagnosis is mostly achieved at a late, 
advanced stage. The median age at diagnosis ranges from 
8 to 10 years, but occasional cases have been reported in 
dogs younger than 5 years [4, 7, 8]. Standard white light 
endoscopy (WLE) with mucosal sampling is convention-
ally used to support the diagnosis, but sometimes full-
thickness gastric biopsy is required [4].
In dogs with GC, non-specific clinical signs of upper 
gastrointestinal (GI) illness tend to appear late in the 
course of disease, at a time point when surgical resection 
is seldom curative since the tumour has already metasta-
sised [4, 7, 9]. In contrast, early diagnosis and resection 
can improve patient survival and welfare. A recent ret-
rospective case series reported a median survival time of 
just 178 days after surgical treatment in 40 dogs with GC 
[9]. However, such survival time was about twice as long 
as those reported for non-operated patients [4, 7, 10]. 
Moreover, 7/40 dogs survived longer than one year after 
surgical resection with prolonged survival times of up to 
1443 days [9].
In humans, early diagnosis of gastric cancer is an 
important factor for long-term survival, and endoscopy 
with gastric mucosal biopsy is the most valuable diagnos-
tic tool [11]. However, gastric mucosal pathology includ-
ing gastric mucous or intestinal metaplasia and dysplasia 
can present as flat lesions that are easily overlooked when 
using WLE alone [11–13]. In human medicine, meta-
plastic and dysplastic changes of the gastric mucosa are 
regarded as preneoplastic and demand systematic staging 
[14]. Therefore, new techniques such as chromoendos-
copy and narrow band imaging have been increasingly 
applied since they allow for better visualization and sam-
pling of gastric mucosal pathology [11, 15, 16]. In veteri-
nary medicine, early endoscopic diagnosis of canine GC 
and its association with mucosal changes regarded as 
preneoplastic have yet to be investigated. Furthermore, 
in contrast to human medicine, protocols for staging GC 
are still missing.
Studies on clinical presentation and early diagnosis 
of GC in dogs remain scarce. Clinical signs consistently 
reported in association with GC are vomiting, anorexia 
and weight loss, but many other signs such as ptyalism, 
gagging, retching, apathy, lethargy and cachexia, and 
occasionally melaena and abdominal pain, can be present 
[2, 4, 7, 10]. Vomiting is the predominant sign associated 
with gastric disease, affecting 53.7% of the dogs with gas-
tric histopathological abnormalities [17]. Appetite loss is 
a common feature of GC [4, 7], but a ravenous appetite 
in spite of weight loss has also been reported [9]. Body 
condition score tends to be reduced in dogs with GC as 
compared to those with gastritis and control dogs [18]. 
Non-specific clinical signs of upper gastrointestinal 
disease may also be related to gastroesophageal reflux 
(GER). GER may cause upper GI signs such as repeti-
tive lip smacking, increased empty swallowing motions, 
chronic intermittent vomiting, sudden unexplained dis-
comfort, belching, drooling, excessive grass eating, pre-
sumed postprandial pain, refusal to eat despite interest, 
regurgitation, retching, excessive surface licking etc. 
Most of these clinical signs of upper GI disease are not 
specific and may also refer to gastritis or chronic inflam-
matory enteropathies [19].
There is conflicting information about the role of grass 
eating in upper GI diseases. In veterinary textbooks, 
this non-specific sign is sometimes considered a pos-
sible mechanism for self-induced vomiting in nauseated 
animals [20]. In contrast, fructo-oligosaccharide supple-
mentation to induce mild GI disturbance in dogs did not 
lead to using grass as an emetic [21]. Other authors con-
cluded that grass-eating should be regarded as a normal 
behaviour of dogs [22–24]. Excessive surface or object 
licking was found to be a behavioural change associated 
with gastrointestinal abnormalities [25]. Currently it is 
unknown to which extent such non-specific signs are 
associated with early or advanced gastric mucosal pathol-
ogy in dogs.
Blood test abnormalities may be absent in dogs with 
GC or tend to be minor, and may include mild anaemia 
(microcytic, hypochromic), hypoglycaemia, hyperpro-
teinaemia, hypoalbuminaemia and increased liver val-
ues [4, 7, 10]. Moreover, dogs with GC can present with 
increased levels of serum C-reactive protein (CRP) and 
decreased serum folate concentrations as compared to 
dogs with chronic gastritis and healthy controls [18]. A 
previous retrospective study in dogs with gastric histo-
pathological abnormalities found that 44% of dogs had 
lymphopenia and 33% had neutrophilia, whereas 14% 
had lymphocytosis [17].
This prospective study is a first attempt to improve the 
early diagnosis of canine GC by comparing clinical his-
tory with endoscopic and histological findings of gastric 
mucosal biopsies in Tervuren and Groenendael BSD with 
and without clinical signs of upper GI disease.
The main objective of the study was to investigate pos-
sible associations of gastric mucosal pathology with sig-
nalment, clinical signs (specific and non-specific signs of 
upper GI disease) and selected standard laboratory tests 
(basic haematology and serum biochemistry; CRP).
The secondary objective was to test for possible asso-
ciations between gastric histolopathogical changes and 
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GC, and their potential involvement as preneoplastic 
changes in dogs.
Methods
Belgian Shepherd dog population survey
An electronic questionnaire was available at the Universi-
ty’s canine research webpage, and it was advertised along 
with links in the website of the Belgian Shepherd Dog 
Association of Finland. The data supplied an epidemio-
logic survey and facilitated the recruitment of dogs to the 
prospective study. Only complete responses concerning 
pedigree-registered dogs were considered. The enquiry 
included:
– Breed variety (Tervuren, Groenendael, Malinois, 
Lakenois);
– Age and sex;
– Feeding (number of meals per day) and diet (com-
mercial processed or raw food, treats);
– Incidence and frequency of vomiting (whether after 
eating or on empty stomach);
– Presence of gagging;
– Presence of ‘altered appetite’ including grass-eating, 
licking surfaces or objects, eating foreign material 
such as soil, faeces, wood, toys etc. (pica);
– Weight loss;
– Being regarded as nervous, or depressed, or with a 
change in behaviour or disposition;
– Previous clinical abnormalities (blood tests, chronic 
disease);
– Current medication.
Patient selection for endoscopic examinations
Survey responses facilitated patient recruitment. The 
owners of BSD older than 5 years were actively contacted 
following the chronological order of response to the sur-
vey, to minimize potential bias, e.g. related to individual 
interest in the outcomes of the examinations or of the 
research. Volunteers were invited for a clinical visit. Dur-
ing anamnesis, the owners were specifically questioned 
about gastrointestinal signs such as vomiting (including 
frequency), and signs of gastroesophageal reflux. Dogs 
underwent physical examination and samples were taken 
for routine laboratory tests including complete blood 
count (CBC), serum biochemistry and faecal parasitol-
ogy. The resulting information was used for patient inclu-
sion and grouping.
Inclusion criteria
Individual dogs were included in accordance with pro-
spectively defined criteria (breed type: Tervuren or 
Groenendael, age above five years). Patient grouping was 
based on the Canine Chronic Enteropathy Clinical Activ-
ity Index (CCECAI), an indicator primarily targeted for 
enteropathies that also includes criteria referable to gas-
tric illness such as patient behaviour, appetite, weight 
loss, and vomiting [26]. Along with CCECAI score, signs 
suggestive of GER such as gagging, retching, belching 
(eructation), lip smacking or licking and repetitive swal-
lowing [19] were used to assign the dogs to mutually 
exclusive groups: with or without clinical signs referable 
to gastric disease. Group A consisted of dogs with CCE-
CAI score ≥ 1 and/or presence of signs of GER. Group B 
comprised dogs with CCECAI = 0 and no signs of GER.
Exclusion criteria
Malinois and Lakenois BSD were excluded from the clini-
cal study due to the lack of evidence for predisposition to 
GC in these breeds [1]. Dogs previously diagnosed with 
concurrent or chronic non-gastic disease, or regarded at 
an increased anaesthetic risk, were also excluded.
Laboratory work
Blood was collected in EDTA tubes for CBC includ-
ing differential white blood cell count (WBC) and in 
serum tubes for biochemistry, including CRP. The result-
ing information was used to support patient inclusion, 
grouping and further statistical analysis. Remaining 
EDTA-blood and serum, as well as faecal samples, were 
frozen at − 20 °C for 6–18  months and then trans-
ferred to storage at − 80 °C. Serum CRP was measured 
10  months later as a single batch, applying a particle-
enhanced turbidimetric immunoassay (Gentian Diagnos-
tics AS, Norway) analyzed using Konelab 60i (Thermo 
Fisher Scientific, USA).
Endoscopic equipment and procedures
Dogs of Groups A and B underwent a clinical study based 
on gastroscopy (endoscope CF180AL, Olympus Europe) 
with mucosal biopsy sampling (disposable forceps FB-
210U, Olympus Europe). The procedures were performed 
under anaesthesia as described elsewhere [27].
Biopsy site selection for focal lesions was facilitated by 
image enhancement using two subsequent techniques: 1) 
narrow band imaging (NBI) [28] and chromoendoscopy 
[16]. NBI was enabled by a specific light source (CLV-180, 
Olympus Europe) and image processor (CV-180, Olym-
pus Europe) to enhance mucosal and vascular assess-
ment [29]. For chromoendoscopy, 0.2% indigo-carmine 
was applied to the mucosal surface with an endoscopic 
spray catheter (PW-5  V-1 Olympus Europe) to improve 
mucosal topographic assessment [16]. A schematic gas-
tric map was used to record visible changes [30]. Vis-
ible lesions from all gastric regions were sampled. In 
the absence of visible lesions, sampling from predefined 
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positions in each gastric region was undertaken, namely 
two samples each from cardia, fundus, greater and lesser 
curvature of gastric body, incisura angularis and pylorus, 
and one from each quadrant of the antrum (clockwise 
at 12, 3, 6 and 9 o’clock) (Fig.  1). An annual follow-up 
endoscopy was offered for dogs diagnosed with dysplas-
tic lesions.
Histologic staining and histopathological assessment
The mucosal samples were placed onto wood chips 
then immersed in 10% formalin for fixation, using sepa-
rate vials labelled in reference to the respective gastric 
region (cardia and fundus; gastric body; incisura; antrum 
and pylorus), or focal lesion (e.g. ulcer; mass; texture 
change). The biopsies were paraffin-embedded, cut into 
four-micrometre-thick sections and stained with hae-
matoxylin–eosin. Special staining techniques (periodic 
acid-Schiff reaction) were applied at the pathologist’s 
discretion. Immuno-histochemical staining for epithelial 
cells was performed using an anti-cytokeratin AE1/AE 
antibody (anti-human Ck AE1/AE3, mouse monoclonal 
M3515, Dako Agilent, USA). The antigens were retrieved 
with 0.01 M citrate buffer at pH 6 and heated for 20 min 
at 99  °C. The signal was revealed according to instruc-
tions for the UltraVision Detection System HRP/DAB kit 
(Thermo Fisher Scientific, USA).
Histological slides were examined by a board-certi-
fied pathologist following the template recommended 
by the World Small Animal Veterinary Association’s 
International Gastrointestinal Standardization Group 
[31]. Mucous metaplasia, glandular dysplasia and GC 
type were recorded [32, 33]. Mucosal inflammation, i.e. 
intraepithelial lymphocytes, and lymphoplasmacytic, 
eosinophilic and neutrophilic infiltration into lamina 
propria, was scored as normal = 0, mild = 1, moderate = 2 
or 3 = severe [34]. An individual mean severity score 
(MSS) of gastric mucosal inflammation was calculated 
from the average of those four scores in each dog, for sta-
tistical purposes.
Statistical methods
For data analysis of the epidemiological survey, signal-
ment, feeding, and clinical and behavioural variables 
were treated as potential risk factors for vomiting, the 
most relevant clinical sign for gastric localization. For 
that purpose, a cut-off for vomiting was set at a frequency 
of ≥ 1 episode per month. The factors were first assessed 
separately with univariate logistic regression. Factors 
deemed significant underwent a multivariate model, 
where main effects were simultaneously included as fixed 
effects.
Concerning data analysis in the endoscopic clinical 
study, the updated clinical information of patients was 
compared with findings from endoscopy and histopa-
thology, including the calculated MSS of gastric mucosal 
inflammation. D’Agostino & Pearson’s test was applied 
for normality of distribution (confirmed when α < 0.05); 
Welch’s t-test was applied in search of sex differences, 
both within groups and independently of grouping, con-
cerning CCECAI score (Group A), WBC, CRP, and MSS, 
using Prism 8 for Windows (GraphPad Software, USA). 
Presence of gastric mucosal atrophy, metaplasia, and dys-
plasia as well as GC were treated as binary variables. The 
effects of vomiting, GER and Group on histopathological 
variables were analysed by logistic regression. The same 
applied for the effects of atrophy, metaplasia, dysplasia 
and GC on the incidence of vomiting and serum CRP 
concentration, as well as the effect of vomiting on CRP. 
Odds ratios (OR) with 95% confidence intervals (CI) were 
calculated to quantify the results of the logistic regres-
sion analyses. The effects of clinical signs and histo-
pathological variables on MSS were analysed by analysis 
Fig. 1 Illustration of the stomach showing standard biopsy sites (red 
dots) used for non‑targeted gastric mucosal sampling ( modified 
from Simone et al. [30]). A: antrum; B: gastric body; G: greater 
curvature; L: lesser curvature; P: pylorus; I: incisura angularis (angular 
fold); C: cardia
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of variance and tests of fixed effects; a calculated Pr > F 
value < 0.05 was deemed significant. The possible asso-
ciation between GC and gastric mucosal atrophy, mucous 
metaplasia and glandular dysplasia was tested with Fish-
er’s exact tests. P-values < 0.05 were considered statisti-
cally significant. Except otherwise noted, SAS System for 
Windows, version 9.4 (SAS Institute Inc., USA) was used 
for statistical analyses.
Results
Belgian Shepherd dog population survey
Out of 232 valid answers to the survey, 120 BSD were 
female (51.7%) and 112 were male (48.3%); 98 were 
Tervuren (42.2%), 64 Groenendael (27.6%), 65 Mali-
nois (28%) and five Lakenois (2.2%). The mean age was 
6.9 ± 3.4 years. Age followed a normal distribution.
Eating history revealed that about 88% of the dogs were 
fed treats, 87.5% were eating grass and 34% were eating 
foreign material. Vomiting once a month or more often 
was reported in 43% of the dogs, gagging in 29% and 
excessive licking of surfaces in 17%. The univariate logis-
tic regression (Fig. 2) indicated an association of vomit-
ing with male sex (P = 0.04), licking surfaces (P = 0.02) 
and gagging (P < 0.001), as well as poor appetite reported 
once a month or more often (P < 0.002), reported change 
in attitude or behaviour (P = 0.001) and being regarded as 
nervous (P = 0.015). Breed variety showed no significance 
as a risk factor for vomiting when Tervuren was com-
pared to Groenendael (P = 0.85) or Malinois (P = 0.1).
Concerning the number of meals, dogs fed once a day 
(18%) apparently vomited less often than those fed more 
often or ad libitum (82%), but significance was unproven 
when “once a day” was compared to “three times a day 
or more often” (P = 0.06) (Fig. 2). Vomiting on an empty 
stomach was reported in 85% of dogs fed once a day and 
in 73% of dogs fed more often. Other predefined risk fac-
tors, such as patient age, eating treats, eating grass, eating 
foreign material, being fed raw food or being regarded as 
depressed, failed to show statistical effect on vomiting 
(Fig. 2).
Although the univariate model suggested vomiting to 
occur twice as often in males than in females, sex failed 
significance as a risk factor for vomiting in the multivari-
ate analysis (P = 0.13) (Figs. 2, 3). The multivariate model 
also contradicted the association of vomiting with sex of 
the dog (P = 0.14), licking objects or surfaces (P = 0.28), 
or being regarded as nervous (P = 0.13). The associa-
tion with vomiting was confirmed for the following fac-
tors: gagging (P = 0.02), change in behaviour or attitude 
(P = 0.01), and refusal to eat, both occurring once a 
month to once a week (P < 0.001) and more often than 
twice a week (P = 0.018) (Fig. 3).
Endoscopic clinical study
Patient inclusion and grouping
Based on the responses to the survey, 79 dogs younger 
than 5 years of age were initially excluded as the dis-
ease is known to affect older dogs. Thirty-five owners of 
BSDs with age >5  years volunteered to bring their dogs 
for assessment. However, five dogs were Malinois and 
were not included in the study. Two male Groenendaels 
were excluded due to concurrent chronic disease such as 
spondylosis, recurrent urinary tract infections and bor-
reliosis diagnosed one year earlier. An asymptomatic, 
severely obese female Tervuren was excluded on account 
of increased anaesthetic risk.
A total of 27 BSD (19 Tervuren, eight Groenendael) 
with a mean age of 9.4 ± 1.7  years underwent gastros-
copy. Age followed a normal distribution both consider-
ing all dogs included and each of the study Groups A and 
B (Fig. 4). Individual patient information is summarized 
in Table 1.
Group A included 16 BSD with signs of gastric dis-
ease (10 Tervuren: three males, two intact and one cas-
trasted, and seven females, three intact and four spayed; 
six Groenendael: two intact males, one intact and three 
spayed females). Mean age was 9.1 ± 1.8  years. Mean 
CCECAI score was 3.1 ± 2.2. All 16 dogs were vomiting 
once a month or more often and six of them also showed 
signs of GER. CCECAI score followed a normal distribu-
tion within Group A. There was no significant difference 
between males (mean CCECAI = 4.2 ± 2.8) and females 
(mean CCECAI = 2.6 ± 1.8) (P = 0.3).
Group B included 11 BSD without signs of gastric 
disease (nine Tervuren: four intact males, one intact 
and four spayed females; two Groenendael: one cas-
trated male and one intact female). Mean age was 
9.8 ± 1.4 years. All of these dogs had CCECAI score = 0 
and no signs referable to GER.
All BSD in the endoscopic study were reported to eat 
grass, except for one (dog 641, Group B).
Laboratory findings
Median WBC in Group A was 5.9 × 109/L (range 3.8–
14.8) and in Group B, 5.6 × 109/L (range 4–9.7); the 
difference was non-significant (P = 0.77). WBC fol-
lowed a normal distribution within Group B (mean 
WBC = 6.2 ± 1.6), but not in Group A. WBC did not dif-
fer between males and females (P = 0.13) with or with-
out regard to grouping. Without regard to grouping, 
median WBC for all dogs was 5.6 × 109/L (range 3.8–
14.8) and seven (25.9%) of the 27 dogs (Group A 4/16, 
Group B 3/11) had WBC below the lower limit of refer-
ence range (5.4–17.4 × 109/L). Two dogs in each group 
(12.9%) had absolute neutropenia (minimum 2 × 109 
neutrophils/L; reference 2.9–13.8 × 109/L), one of which 
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Fig. 2 Forest plot of odds ratios for vomiting from the univariate analyses of signalment, clinical signs, feeding and behaviour
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had also lymphopenia (dog 652; Group A; 0.89 × 109 
lymphocytes/L; reference 1–5.4 × 109/L).
Mean serum CRP levels did not differ between Group 
A (median = 10.6  mg/L; range 5.3–45.1) and Group 
B (median = 8.7  mg/L; range 6.5–13.5) (P = 0.08), nor 
between males and females (P = 0.63). Serum CRP 
was normally distributed only within Group B (mean 
CRP = 9.6 ± 2.3 mg/L). The fixed effect of CRP on CCE-
CAI score was nearly significant at Pr > F = 0.06.
Association of endoscopic and histopathological findings 
with clinical signs and laboratory results
At endoscopy, 5/27 dogs (one in Group A; four in Group 
B) had no distinct focal changes, hence the standard 
sampling protocol was applied (Fig.  1). Visible mucosal 
changes were present in 22/27 BSD: 21 dogs had changes 
affecting the gastric body and one dog had only minor 
focal changes restricted to the pyloric antrum. Endo-
scopic biopsy of both diffuse and focal mucosal changes 
supplied the respective histopathological diagnoses 
(Fig. 5).
The histopathological MSS did not differ significantly 
between Group A (1.6 ± 0.8) and Group B (1.3 ± 0.5) 
(P = 0.08), nor between males (1.2 ± 0.8) and females 
(1.6 ± 0.5) (P = 0.21). The MSS followed a normal dis-
tribution within both groups. Mean MSS was sig-
nificantly higher in dogs vomiting once a month or 
more often (1.6 ± 0.7), than in those for which vomit-
ing was reported as less frequent or absent (1.3 ± 0.6) 
(Pr > F = 0.028). Mean MSS tended to be higher in 
dogs diagnosed with glandular dysplasia (1.7 ± 0.6) 
than in those without dysplastic changes (1.2 ± 0.6) 
(Pr > F = 0.078). Moreover, an increased odds ratio for 
vomiting [OR = 9.9 (1.5–63.7)] was confirmed for dogs 
diagnosed with glandular dysplasia (P = 0.016) but not 
with mucosal atrophy, mucous metaplasia or GC.
Logistic regression analysis showed no statistical dif-
ference between Groups A and B concerning mucosal 
atrophy (A: 10/16; B: 10/11), mucous metaplasia (A: 
4/16; B: 3/11), glandular dysplasia (A: 10/16; B: 3/11) 
nor GC (A: 4/16; B: 2/11). Regardless of grouping, most 
BSD had gastric mucosal atrophy (20/27), followed by 
glandular dysplasia (13/27), mucous metaplasia (6/27), 
and GC (6/27). Factors such as CCECAI score, GER 
and laboratory tests showed no significant associations 
with histopathology. Individual findings are summa-
rized in Table 1.
Six dogs were diagnosed with GC (Tables  1, 2). All 
dogs with GC were over seven years of age (median = 9.2; 
range 7.2–11.2). GC concurred with changes elsewhere 
in the gastric mucosa in both groups, namely mucous 
metaplasia in 4/6, and mucosal dysplasia in all six dogs. 
Fisher’s exact test revealed a significant association of GC 
with mucous metaplasia (P = 0.026) and glandular dys-
plasia (P = 0.004), but not with mucosal atrophy (P = 1). 
All neoplasms were gastric adenocarcinomas (Table  2): 
1/6 tubular type and 5/6 partly or completely of the dif-
fuse, non-cohesive type (including one mucinous adeno-
carcinoma). In two patients (dog 711, Group A; dog 641, 
Group B), the endoscopic changes were more subtle, with 
no visible ulceration, nor bleeding after full insufflation. 
In the other four dogs, GC was diagnosed from ulcerated, 
bleeding masses.
Comparison of the CRP levels of all dogs in the study 
with histopathological findings including presence of 
GC (P = 0.44) failed significance. Notably, serum CRP 
of dog 686 was 45.1 mg/L, well over two standard devia-
tions above the mean and therefore considered an outlier. 
When the subgroup of four dogs with ulcerated GC were 
compared to the other 20 dogs (i.e. except the above-
mentioned dogs 686, 711 and 641), the odds ratio for an 
increased CRP with ulcerated GC was nearly significant 
(P = 0.06), OR = 1.2 (0.99–1.48).
Neoplastic lesions were also accompanied by moderate 
(4/6) to severe (2/6) lymphoplasmacytic infiltration, and 
mild (1/6) to moderate (3/6, all non-cohesive GC) eosin-
ophilic infiltration. The GC patient with the most severe 
clinical disease (CCECAI = 8) was both the youngest dog 
with GC (7.2  years) and the only one with a mucinous 
adenocarcinoma (dog 658).
In one case (dog 680; Group A), endoscopy revealed a 
marked fold of 4 × 7  cm in the distal greater curvature 
protruding into the lumen (Fig. 6). The change was soft, 
Fig. 3 Forest plot of odds ratios for vomiting from the multivariate 
analyses of signalment, clinical signs and behaviour
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flexible and the mucosa lifted normally from the wall 
when taking biopsies (i.e. non-lifting sign absent) [35]. 
Its apex appeared superficially ulcerated and hyperae-
mic, with a disrupted blood vessel pattern in NBI. The 
most severe histological finding consisted of marked 
glandular dysplasia. At a voluntary follow-up endoscopy 
one year later, the change presented as more voluminous 
and clearly polypoid. The irregularity of the surrounding 
mucosa had grown in extension and coarseness, affect-
ing most of the ventral gastric body towards the cardia. 
Fig. 4 Flowchart showing patient recruitment, inclusion, most severe diagnosis and outcome of affected dogs. During the first phase, the answers 
to the survey allowed to contact owners of potential study patients. The second phase involved clinical assessment including updated anamnesis, 
physical examination, blood and faecal sampling. In the third phase, dogs included in the study were scoped, with biopsy sampling leading to final 
histopathological diagnosis
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Surgery revealed no evidence of lymph node involvement 
and the polypoid mass was removed with a margin of 
1.5 cm. Histopathology diagnosed a tubular adenocarci-
noma with multifocal infiltration into the submucosa and 
clear margins. Four months later, no evidence for dys-
plastic nor neoplastic changes in the prominent edges of 
the resection scar was found with endoscopic biopsy: his-
topathology confirmed oedema, mild epithelial damage, 
lymphoplasmacytic gastritis and fibrosis. Biopsies from 
elsewhere in the gastric body showed mucous metapla-
sia. The patient had remained asymptomatic at the time 
of manuscript submission, a year after surgery.
Discussion
The online survey revealed that BSD owners in Finland 
report a high percentage of clinical signs of gastric dis-
ease. Vomiting once a month or more often was reported 
in 43% of dogs. Vomiting was associated with poor 
appetite, gagging and changes in the dog´s attitude or 
behaviour, which is coherent with upper gastrointestinal 
malaise. The reported incidence of vomiting may sug-
gest a relatively high prevalence of gastric illness in the 
BSD population. However, participation in the survey 
was voluntary. Owners were contacted in chronologi-
cal order of response to minimize potential bias, but the 
Table 1 Belgian Shepherd dogs with  (Group A) or  without  upper gastrointestinal clinical signs (Group B) included 
in endoscopic study: clinical presentation, blood parameters and histopathological changes
Age in years. M: male; F: female; n: neutered, CCECAI: canine chronic enteropathy clinical activity index, GER: signs referable to gastroesophageal reflux (gagging, 
eructation, smacking, licking lips and swallowing), WBC: total leucocyte count (reference range: 5.4–17.4 × 109/L), CRP: C-reactive protein in serum (reference 
value: < 10 mg/L), A: gastric mucosal atrophy; M: mucous metaplasia; D: glandular dysplasia; U-: ulcerated; GC: gastric carcinoma, N: normal histology, absence 
of pathological changes, MSS: mean severity score (0 = normal; 1 = mild; 2 = moderate; 3 = severe); average of four histopathological scores [31]: intraepithelial 
lymphocyte count and inflammatory infiltrations in lamina propria (lymphoplasmacytic, eosinophilic and neutrophilic)
Patient no Breed type Age Clinical presentation Blood work Histology
Dog, sex CCECAI score GER WBC CRP Findings MSS
Group A
642, M Tervuren 9.9 6 – 14.8 29.1 1
644, Fn Tervuren 10.1 2 – 6.6 8.8 A 2
645, Fn Tervuren 11.6 3 – 7.2 14.7 2
646, M Groenendael 11.2 3 – 5.6 9.6 A, M, D 1
647, Fn Tervuren 10.1 1 – 6.3 15.3 M, D, U‑GC 2
649, F Tervuren 7.9 2 – 6.3 8.2 A 2
650, M Groenendael 10.6 3 – 6.5 7.4 A 2
652, Mn Tervuren 10.1 1 – 3.8 10.7 D 2
655, Fn Groenendael 9.1 3 Yes 5.4 10.5 A 1
658, M Tervuren 7.2 8 – 8.0 15.5 A, M, D, U‑GC 2
664, Fn Tervuren 10.4 1 – 5.1 5.9 A, D 2
677, F Groenendael 8.3 6 Yes 5.4 24.4 A, D, U‑GC 2
680, F Tervuren 5.5 5 Yes 6.6 5.3 M, D 1
686, F Tervuren 5.6 2 Yes 5.5 45.1 A, D 2
687, Fn Groenendael 9.7 4 Yes 5.3 10.0 D 3
711, Fn Groenendael 8.3 0 Yes 4.9 11.0 A, D, GC 2
Group B
641, M Tervuren 10.8 0 – 9.7 9.4 A, M, D, GC 2
679, Fn Tervuren 9.0 0 – 4.0 12.1 N 2
703, M Tervuren 9.0 0 – 7.8 8.5 A 2
719, Fn Tervuren 11.3 0 – 5.6 12.0 A 1
721, Fn Tervuren 11.2 0 – 5.3 13.5 A, M, D, U‑GC 1
722, M Tervuren 11.2 0 – 7.6 6.5 A, M,D 3
723, M Tervuren 11.0 0 – 7.0 6.8 A 1
724, F Groenendael 7.6 0 – 4.9 9.4 A 1
747, F Tervuren 8.2 0 – 5.4 8.7 A 1
749, Mn Groenendael 8.3 0 – 5.6 8.3 A 0
750, Fn Tervuren 10.1 0 – 5.6 8.4 A 2
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Fig. 5 Endoscopic images showing examples of mucosal changes in the gastric body. a Mucous metaplasia (dog 646); b glandular dysplasia (dog 
658), narrow band imaging (NBI); c early adenocarcinoma (dog 647); D: ulcerated carcinoma (dog 721; NBI)
Table 2 Breed type, sex, age and classification of gastric carcinomas diagnosed in Belgian Shepherd dogs with (Group A) 
or without upper gastrointestinal clinical signs (Group B)
Dog no Breed type Sex Patient Group Age at diagnosis (years) Tumour classification [32, 33]
641 Tervuren M B 10.8 Tubular adenocarcinoma
647 Tervuren F A 10.1 Tubular with areas progressing 
to signet ring cell carcinoma
658 Tervuren M A 7.2 Mucinous adenocarcinoma
677 Groenendael F A 8.3 Signet ring cell carcinoma
711 Tervuren F A 8.3 Signet ring cell carcinoma
721 Groenendael F B 11.2 Tubular with areas progressing 
to signet ring cell carcinoma
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possibility of volunteer bias [36], e.g. increased interest 
by those concerned about the outcomes of their individ-
ual dog’s examinations or impacts of the research, can-
not be excluded. Therefore, conclusions were drawn with 
caution.
Eating grass was a common behaviour, reported in 
87.5% of all dogs in the survey and in all but one of the 
patients undergoing endoscopy (dog 641, diagnosed with 
an early tubular adenocarcinoma). Eating grass failed to 
show significant association with vomiting. Plant-eating 
has been hypothesized to serve various purposes such as 
inducing vomiting or controlling gastrointestinal para-
site burden [20, 23]. About 70% of all dogs eat plants on 
a daily or weekly basis, with grass being the most com-
monly consumed. However, very few dogs appear ill 
before (9%) or tend to vomit afterwards (22%) [22]. Eat-
ing grass has been regarded as normal behaviour in a 
controlled trial involving 12 mixed-breed dogs [24]. 
In our study, the actual frequency and amount of grass 
ingested were not recorded which to some degree limits 
the assessment of a possible association with gastric dis-
ease. Besides, eating foreign material also failed to show 
association with vomiting.
Vomiting was not applied as the single criterion for 
patient inclusion to Group A (with GI signs) or B (no GI 
signs). In the absence of a standardized, objective clinical 
measure of gastric disease, the Canine Chronic Enteropa-
thy Clinical Activity Index was applied. The CCECAI is 
used to score signs such as inactivity, inappetence, weight 
loss and vomiting, which are recognized with upper 
Fig. 6 Dog 680. Overview and close‑up endoscopic images of a focal mucosal change diagnosed as dysplastic both at initial examination (a, b) 
and one year later (c), i.e. after the study had ended. a–c White light endoscopy. d Narrow band imaging close‑up just before surgical resection 
(confirmed tubular adenocarcinoma at histology)
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gastrointestinal disorders, including GC [4, 18]. Never-
theless, a dog vomiting less often than once a week would 
score zero in CCECAI, whereas vomiting once a week 
would be regarded as mild, scoring one point. Subtle or 
initial illness might be overlooked in a patient with occult 
GC, presenting occasional vomiting as the only clinical 
sign. To avoid this drawback, a wider range of clinical 
signs which are often associated with GER were used for 
inclusion to Group A. Thus, the dogs in Group B could 
be clearly considered asymptomatic in regard to GI signs.
WBC below the reference range occurred in dogs of 
both groups (7/27; 25.9%), with and without GC. Low 
WBC in itself does not entail an increased risk for anaes-
thesia or endoscopic procedures and was therefore not 
regarded as a reason for exclusion. Leukopenia has been 
proposed as common and possibly even physiological 
for Belgian Tervuren in a study in North America [37], 
but the condition was unconfirmed in European line-
ages: Gommeren et al. [38] found leukopenia in only 1/94 
healthy Belgian Tervuren, although WBC significantly 
decreased with patient age. Our study in BSD older than 
five years revealed neither American progenitors in the 
pedigree of dogs with low WBC, nor an association of age 
with WBC. A previous retrospective study [17] reported 
lymphopenia in 44% and leucocytosis in 21% of dogs of 
various breeds with gastric histopathological abnormali-
ties. Nevertheless, low WBC showed no association with 
either clinical or histopathological variables in BSD in 
this study.
Serum CRP has been reported as increased in dogs 
diagnosed with GC as compared to dogs with chronic 
gastritis and control dogs [18]. In humans with GC, CRP 
shows limited evidence as a single prognostic marker 
[39]. Our study found no difference in CRP between 
Groups A and B, nor when the six GC patients were 
compared with all other dogs (Table 1). However, when 
the subgroup of dogs with ulcerated GC was compared 
with the other 20 dogs (except two non-ulcerative GC 
and one outlying CRP result), logistic regression pointed 
towards a possible association of CRP with ulcerated GC 
(P = 0.06). The analysis is underpowered as it draws on 
the comparison of only four dogs with visibly ulcerated 
GC and 20 dogs without GC. Measuring CRP in stored 
samples might be erroneous, but studies reassure that, in 
human serum frozen at − 20 °C, CRP remains stable for 
at least 1026 days [40].
Previous reports have shown higher incidence of GC in 
male dogs [1]. Our online survey results suggested that 
male BSD are approximately twice as likely to vomit as 
females. However, our relatively small sample size in the 
endoscopic study prevents assessing sex as a factor for 
GC (four of the six dogs with GC were females). Moreo-
ver, no statistic difference was found between males and 
females concerning CCECAI score, CRP, WBC, or the 
MSS of gastric biopsies.
None of the BSD in our study had intestinal metapla-
sia diagnosed from endoscopic biopsies. This suggests 
that, at least in this population, the histological path-
way towards GC does not follow the human linear cas-
cade proposed by Correa [44]. The most common gastric 
tumour in man, arising via that model, is the intestinal-
type gastric adenocarcinoma [11]. In our BSD study 
population, however, different types of carcinoma were 
described: 1/6 intestinal/tubular type and 5/6 present-
ing traits of the diffuse, non-cohesive type (including one 
mucinous adenocarcinoma). These findings in BSD fur-
ther illustrate possibly divergent pathogenetic pathways 
in canine GC [4].
Extensive efforts to standardize inflammatory changes 
in canine gastrointestinal pathology have contributed 
to diagnostic capabilities in this field [31, 34, 41]. How-
ever, the occurrence and role of possible preneoplas-
tic mucosal changes in dogs has not been as thoroughly 
studied and it remains unproven whether carcinogenic 
mechanisms established in humans are relevant in dogs. 
In man, the classic pathway of carcinogenesis is ascribed 
to chronic, atrophic gastritis followed by intestinal meta-
plasia and dysplasia, which are recognized as preneoplas-
tic changes [44]. Regardless of clinical signs, or severity 
of histopathological changes, 74% of our dogs had gastric 
mucosal atrophy and it carried no statistical association 
with GC. In veterinary medicine, only gastric mucous 
metaplasia has been mentioned as potentially preneo-
plastic [33]. Out of the six BSD with GC, five also had 
mucosal atrophy, four had mucous metaplasia, and all 
six had dysplastic changes as well as moderate to severe 
chronic inflammation, including eosinophilic infiltra-
tion, affecting mainly the gastric body. This differs from 
the neuroendocrine carcinomas described in four of 
eight Norwegian Lundehund with gastric neoplasia [42], 
wherein only mild antral inflammation has been reported 
[43].
Relevant histopathological changes, including GC, 
were diagnosed in both groups A and B. Our approach 
to group allocation involved an array of gastrointestinal 
signs, which were analysed as presence/absence of signs 
of GER and individual scores for CCECAI. Ultimately, 
vomiting was the only sign showing an important cor-
relation with MSS and notably with glandular dysplasia 
(OR = 9.9). There was a trend for increased MSS along 
with glandular dysplasia (Pr > F = 0.078, close to sig-
nificance). That may suggest a possible pathophysiologi-
cal association of chronic gastritis with carcinogenesis 
also in BSD, warranting studies with higher statistical 
power. Both mucous metaplasia and especially glandular 
Page 13 of 15Cândido et al. Acta Vet Scand            (2021) 63:7  
dysplasia correlated with GC, which is also the case in 
the classic human model of gastric carcinogenesis [4, 44].
Vomiting is regarded as the cardinal sign for gastric 
localization and consistently mentioned in previous stud-
ies on canine GC [4, 7–10, 18]. Nevertheless, vomiting 
was mild or absent in some GC cases, and it showed no 
correlation with mucosal atrophy, mucous metaplasia, 
nor GC. Moreover, 6/27 (22%) BSD over 5.5 years of age 
were diagnosed with GC regardless of clinical condition. 
This further corroborates a marked predisposition to GC 
in these ageing Tervuren and Groenendael BSD, as GC is 
rare in dogs, except for a few predisposed breeds [1, 6]. 
Even more importantly, it shows that gastric pathology 
including GC can occur as an occult disease in affected 
dogs. Such evidence supports a clinical indication for the 
procurement of gastric biopsies in ageing BSD, before the 
lesions become locally advanced or metastasise, carrying 
a poor prognosis.
Early detection of GC can potentially improve patient 
outcome, enabling surgical removal before such tumours 
have developed in size and clinical severity, as illustrated 
by the follow-up of dog 680 (group B) as well as another 
study showing prolonged survival time for a few dogs 
treated having only minimally invasive GC [9]. Timely 
diagnosis may facilitate potential surgical or minimally 
invasive treatment and avoid unnecessary suffering, as well 
as contribute to the understanding of GC pathophysiol-
ogy in dogs. In order to clarify whether mucous metapla-
sia and glandular dysplasia of canine gastric mucosa are 
preneoplastic changes, as already established in human 
medicine, future clinical studies should involve endoscopic 
surveillance of affected dogs. For such studies, recording 
the exact localization of lesions in a schematic gastric map 
could be useful to investigate the development of gastric 
pathology in subsequent endoscopies [30].
Alongside non-predisposed breeds, a great challenge 
remains in diagnosing the asymptomatic GC cases. 
Extensive endoscopic screening of healthy BSD to diag-
nose occult GC may be unwarranted and thus ethically 
questionable. As opposed to veterinary medicine, several 
standard laboratory tests and tumour markers are use-
ful in screening and prognosing human GC [45–52]. As 
shown in our study, CRP correlates well with prognosis, 
but as a non-specific inflammatory protein it shows lim-
ited level of evidence and potential as an early marker 
[53]. Therefore, future research aiming at early diagnosis 
of GC in dogs should also focus on non-invasive serum 
or faecal biomarkers [18].
Conclusions
This study on ageing Tervuren and Groenendael BSD 
showed a high proportion of dogs with clinical signs of 
gastric disease regardless of the presence of GC. Gastric 
mucosal pathology included atrophy, mucous metaplasia, 
glandular dysplasia and GC, which were found irrespec-
tive of clinical signs.
Recurrent vomiting correlated with the severity of 
mucosal inflammation and presence of dysplasia and 
should be regarded as an indication for endoscopy and 
gastric mucosal sampling in BSD. Moreover, the signifi-
cant association of GC with metaplasia and dysplasia, 
which are regarded as premalignant in humans, sup-
ports the indication for endoscopic surveillance in BSD. 
However, extensive endoscopic screening due to the 
occurrence of occult gastric disease remains unrealistic. 
Therefore, sensitive and specific indicators of GC such 
as serum or faecal biomarkers are warranted to promote 
early diagnosis of canine GC.
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